Ovarian PRP for Diminished Ovarian Reserve

Recruiting now · Not applicable · Has a placebo group

Conditions studied: Diminished Ovarian Reserve

In brief

This prospective double-blinded randomized placebo control study aims to determine if In Vitro Fertilization (IVF) outcomes are improved by ovarian platelet-rich plasma injections (oPRP) for women diagnosed with diminished ovarian reserve (DOR). Women with DOR notoriously have the lowest chance of pregnancy and live birth compared to age-matched peers with a normal or robust ovarian reserve.

Key facts

Study ID

NCT05790655

Run by

Generation Next Fertility

People needed

230

Starts

2023-10-07

Expected to finish

2025-12-31

Last updated by the study team

2025-02-13

Who can join

Age: 35 and older, up to 42. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Clinical diagnosis of diminished ovarian reserve
• Clinical diagnosis of poor ovarian response
• Women age 35-42

You may not qualify if…

• Clinical diagnosis of premature ovarian failure
• Clinical diagnosis of menopause.
• Under 35 years of age
• Over 42 years of age

Where it is running

• Generation Next Fertility — New York, New York, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.